SHR-A1811 Injection Clinical Trials
3 recruitingDrug
Phase 23
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer
Recurrent or Metastatic Cervical Cancer
Jiangsu HengRui Medicine Co., Ltd.60 enrolled2 locationsNCT07051486
Recruiting
Phase 2
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
Gastroesophageal Junction AdenocarcinomaMetastatic Gastric CancerAdvanced Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd.351 enrolled2 locationsNCT07102901
Recruiting
Phase 2
SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer
HR Positive/HER2 Low Breast Cancer
Shengjing Hospital93 enrolled1 locationNCT06340230